Obstructive sleep apnea and atherosclerosis.

Area of Science:

• Cardiovascular Science
• Sleep Medicine
• Immunology

Background:

• Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and mortality.
• Atherosclerosis, indicated by increased intima-media thickness, is prevalent in OSA patients, even without other risk factors.
• Early atherosclerosis may mediate the link between OSA and cardiovascular complications.

Purpose of the Study:

• To explore the role of early atherosclerosis as an intermediary mechanism in OSA-related cardiovascular morbidity.
• To investigate the inflammatory processes and vascular wall changes in OSA that contribute to atherogenesis.
• To assess the potential reversibility of these vascular changes with treatment.

Main Methods:

• Review of existing evidence on OSA, atherosclerosis, and cardiovascular outcomes.
• Analysis of studies on intermittent hypoxia models in rodents.
• Examination of vascular wall changes, including leukocyte adhesion molecules, in OSA patients.

Main Results:

• Intermittent hypoxia in animal models triggers atherogenesis.
• OSA is associated with increased leukocyte rolling and adhesion molecule expression.
• Early vascular wall changes observed in OSA patients may be reversible with continuous positive airway pressure (CPAP).

Conclusions:

• Early atherosclerosis is a significant intermediary mechanism linking OSA to cardiovascular disease.
• Inflammatory processes and vascular wall alterations play a key role in OSA-driven atherogenesis.
• Further research is needed to identify at-risk individuals for timely OSA treatment and potential combination therapies.